Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by NotinKansas


V.TLT

RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Releases 1Q2023 Interim Financial Statements

I don’t believe there are formal rules prescribing how data in a swimmers...

May 31, 2023

V.TLT

RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Releases 1Q2023 Interim Financial Statements

I agree with your sentiment, but perverse and subversive I wouldn’t call it...

May 31, 2023

V.TLT

RE:# of NR Patients in Swimmer Plots (May 10th & May 30th)

Hi RH, I think it is one from the three patients on lines 23-25 in 10 May’s...

May 31, 2023

V.TLT

RE:RE:RE:RE:New Press Release - Theralase(R) Releases 1Q2023 Interim Financial Statements

Pandora, there is indeed some chronology in the plot as obviously the...

May 31, 2023

V.TLT

RE:Trial Result Tables

To identify the results achieved by the 12 initially undertreated one has to...

May 3, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:72% CR at any point in time.

Wildbird, once again, I’m neither pretending nor misleading. All the numbers...

May 1, 2023

V.TLT

RE:I dont try to understand the numbers anymore.

Lesalpes, don't give up, the swimmers' plot provides exactly what you...

May 1, 2023

V.TLT

RE:RE:RE:RE:RE:72% CR at any point in time.

Sorry, I read you wrong, nothing too rosy in your numbers indeed. I'm...

May 1, 2023

V.TLT

RE:RE:RE:72% CR at any point in time.

CS, I agree that removing the 12 undertreated would provide a clearer picture...

May 1, 2023

V.TLT

RE:RE:RE:RE:72% CR at any point in time.

I agree that the 12 undertreated should be removed from the analysis, but...

May 1, 2023

V.TLT

RE:RE:RE:72% CR at any point in time.

Hi Wildbird, no offense, I appreciate your attempts to help us arrive at a...

May 1, 2023

V.TLT

RE:72% CR at any point in time.

Not sure if that’s a fair comparison Wildbird. In the swimmer plots the well...

April 30, 2023

V.TLT

RE:RE:RE:Excel spreadsheet display of new data from MDA

Hi DJDawg, I tend to look at data presented in MD&A's alone - not...

April 28, 2023

V.TLT

RE:Excel spreadsheet display of new data from MDA

Thanks DJDawg, great job. I just finished going through the numbers myself...

April 27, 2023

V.TLT

RE:RE:An Update on Key Areas of Progress In Bladder Cancer

We are mentioned, somewhere halfway, in the paragraph starting with "...

March 30, 2023

V.TLT

RE:%s of the optimized group @450-days: 43.7% CR and 64.4% TR

SF, no need to speculate about the results of the non-optimized/undertreated...

February 6, 2023

V.TLT

The optimized cohort in the latest report

If one deducts from the results reported in the MD&A of 30 August (a) the...

September 10, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:Insiders continue to Buy 750 k in warrants May 14 2022

To me, Rodger and Kristina’s willingness to invest another $225k in the...

May 25, 2022

V.TLT

Progress in trial results since 5 April

While the total treated patient population has remained stable, the latest MD...

May 2, 2022

V.TLT

Here’s hoping

that if the new patient data merit it, the company will opt for a more...

February 20, 2022

1 2 Next